AN2 Therapeutics, Inc. (ANTX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary 
XHAM $
3. 38
-0.22
-6.1111%
$
158.47M Market Cap
- P/E Ratio
- Div Yield
281,700 Volume
- Eps
$ 3.6
Previous Close 
Want to track ANTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AN2 Therapeutics, Inc. (ANTX) Statistics
Valuation metrics
Market Cap 158.47M
Enterprise value 83.23M
Trailing P/E (ttm) -3.16
Forward P/E -
PEG ratio -0.22
Price/Sales (ttm) -
Price/Book (mrq) 1.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 382.14K
Average volume (90 days) 251.53K
Price summary
52-Week low 1
52-Week high 7.19
Beta -
50-Day moving average 5.07
200-Day moving average 4.77
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.44%
Return on equity -0.54%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.75
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 14.32%
Book value per share (mrq) 1.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
